arabinofuranosylcytosine triphosphate has been researched along with arabinofuranosyluracil in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (56.25) | 18.7374 |
1990's | 2 (12.50) | 18.2507 |
2000's | 3 (18.75) | 29.6817 |
2010's | 2 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rustum, YM | 1 |
Hilliard, S; Peck, C; Roberts, D; Wingo, W | 1 |
Aherne, GW; Marks, VM; Piall, EM | 1 |
Büchner, T; Hiddemann, W; Kewer, U; Reuter, C; Rolf, C; Schleyer, E; Uhrmeister, C; Unterhalt, M; Wörmann, B; Zühlsdorf, M | 1 |
Aherne, GW; Dawson, VM; Ford, J; Kees, UR; Piall, E | 1 |
Cheng, YC; Chiou, JF; Huang, ES; Mar, EC | 1 |
Griffin, JD; Kufe, DW; Spriggs, DR | 1 |
Preisler, HD; Riva, C; Rustum, YM | 1 |
Bunch, C; Grahame-Smith, DG; Harris, AL; Potter, CG | 1 |
Mazrimas, JA; Pallavicini, MG | 1 |
Büchner, T; Hiddemann, W; Kern, W; Schleyer, E; Unterhalt, M | 1 |
Furman, P; Martin, P; Pichoud, C; Seignères, B; Trépo, C; Zoulim, F | 1 |
Buck, S; Ge, Y; Jensen, TL; Matherly, LH; Ravindranath, Y; Stout, ML; Tatman, DA; Taub, JW; Thomas, RL | 1 |
Kang, MJ; Kim, DH; Lee, HS; Lee, J; Yoo, BC; Yoo, HH; Yoo, HW | 1 |
Jiang, S; Qiao, X; Shao, Y; Shi, W; Tang, J; Xie, X; Zhang, X; Zhou, X | 1 |
Jiang, X; Liang, D; Wang, W; Yin, S | 1 |
1 trial(s) available for arabinofuranosylcytosine triphosphate and arabinofuranosyluracil
Article | Year |
---|---|
Rapid quantitative determination of L-FMAU-TP from human peripheral-blood mononuclear cells of hepatitis B virus-infected patients treated with L-FMAU by ion-pairing, reverse-phase, liquid chromatography/electrospray tandem mass spectrometry.
Topics: Adult; Antiviral Agents; Arabinofuranosylcytosine Triphosphate; Arabinofuranosyluracil; Chromatography, High Pressure Liquid; Half-Life; Hepatitis B; Humans; Mass Spectrometry; Middle Aged; Reproducibility of Results | 2006 |
15 other study(ies) available for arabinofuranosylcytosine triphosphate and arabinofuranosyluracil
Article | Year |
---|---|
Multiple determinants of antimetabolite action in humans.
Topics: Animals; Antimetabolites, Antineoplastic; Arabinofuranosylcytosine Triphosphate; Arabinofuranosyluracil; Cytarabine; Daunorubicin; Deamination; DNA; Doxorubicin; Drug Resistance; Humans; Leukemia, Myeloid, Acute; Neoplasms, Experimental | 1979 |
Methotrexate-induced changes in the levels of 1-beta-D-arabinofuranosylcytosine triphosphate in L1210 cells.
Topics: Animals; Arabinofuranosylcytosine Triphosphate; Arabinofuranosyluracil; Arabinonucleotides; Cytarabine; Deoxycytidine Kinase; Drug Therapy, Combination; Female; Leukemia L1210; Methotrexate; Mice; Mice, Inbred Strains; Time Factors | 1979 |
A radioimmunoassay for cytosine arabinoside.
Topics: Animals; Arabinofuranosylcytosine Triphosphate; Arabinofuranosyluracil; Cross Reactions; Cytarabine; Humans; Immune Sera; Ovalbumin; Radioimmunoassay; Sheep | 1979 |
Differences in the intracellular pharmacokinetics of cytosine arabinoside (AraC) between circulating leukemic blasts and normal mononuclear blood cells.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Arabinofuranosylcytosine Triphosphate; Arabinofuranosyluracil; Cytarabine; Daunorubicin; Drug Administration Schedule; Humans; Leukemia, Myeloid; Leukocytes, Mononuclear; Lymphoma, Non-Hodgkin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Thioguanine | 1992 |
Development of resistance to 1-beta-D-arabinofuranosylcytosine after high-dose treatment in childhood lymphoblastic leukemia: analysis of resistance mechanism in established cell lines.
Topics: Arabinofuranosylcytosine Triphosphate; Arabinofuranosyluracil; Child; Cytarabine; Drug Resistance; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Time Factors; Tumor Cells, Cultured | 1989 |
Human cytomegalovirus-induced DNA polymerase and its interaction with the triphosphates of 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-methyluracil, -5-iodocytosine, and -5-methylcytosine.
Topics: Antiviral Agents; Arabinofuranosylcytosine Triphosphate; Arabinofuranosyluracil; Arabinonucleotides; Cytarabine; Cytomegalovirus; DNA Replication; DNA-Directed DNA Polymerase; Enzyme Induction; Humans; Kinetics; Nucleic Acid Synthesis Inhibitors; Substrate Specificity; Virus Replication | 1985 |
Pharmacologic studies of low-dose and high-dose continuous infusion cytosine arabinoside.
Topics: Adult; Aged; Arabinofuranosylcytosine Triphosphate; Arabinofuranosyluracil; Cytarabine; DNA Replication; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Middle Aged; Replicon; Thrombocytopenia | 1987 |
Pharmacokinetic parameters of 1-beta-D-arabinofuranosylcytosine (ara-C) and their relationship to intracellular metabolism of ara-C, toxicity, and response of patients with acute nonlymphocytic leukemia treated with conventional and high-dose ara-C.
Topics: Acute Disease; Animals; Arabinofuranosylcytosine Triphosphate; Arabinofuranosyluracil; Cytarabine; Drug Administration Schedule; Humans; Leukemia; Leukemia L1210; Metabolic Clearance Rate; Mice; Uridine Kinase | 1987 |
Cytosine arabinoside deamination in human leukaemic myeloblasts and resistance to cytosine arabinoside therapy.
Topics: Adult; Arabinofuranosylcytosine Triphosphate; Arabinofuranosyluracil; Bone Marrow; Cells, Cultured; Cytarabine; Deamination; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Resistance; Humans; Leukemia, Myeloid, Acute; Tetrahydrouridine | 1981 |
High-performance liquid chromatographic analysis of cytosine arabinoside and metabolites in biological samples.
Topics: Animals; Arabinofuranosylcytosine Triphosphate; Arabinofuranosyluracil; Chromatography, High Pressure Liquid; Cytarabine; Female; Mice; Neoplasms, Experimental | 1980 |
Optimizing therapy for acute myeloid leukemia based on differences in intracellular metabolism of cytosine arabinoside between leukemic blasts and normal mononuclear blood cells.
Topics: Acute Disease; Antimetabolites, Antineoplastic; Arabinofuranosylcytosine Triphosphate; Arabinofuranosyluracil; Cytarabine; Female; Humans; Leukemia, Myeloid; Leukocytes, Mononuclear; Male | 1996 |
Inhibitory activity of dioxolane purine analogs on wild-type and lamivudine-resistant mutants of hepadnaviruses.
Topics: Animals; Arabinofuranosylcytosine Triphosphate; Arabinofuranosyluracil; Carcinoma, Hepatocellular; Cytidine Triphosphate; Dioxolanes; DNA Replication; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Viral; Gene Expression Regulation, Viral; Guanosine; Hepadnaviridae Infections; Hepatitis B virus; Hepatitis B Virus, Duck; Hepatitis, Viral, Animal; Hepatocytes; Humans; Lamivudine; Liver Neoplasms; Mutation; Purine Nucleosides; Reverse Transcriptase Inhibitors; Thiophenes; Tumor Cells, Cultured | 2002 |
GATA1, cytidine deaminase, and the high cure rate of Down syndrome children with acute megakaryocytic leukemia.
Topics: Antimetabolites, Antineoplastic; Arabinofuranosylcytosine Triphosphate; Arabinofuranosyluracil; Blotting, Western; Child; Cytarabine; Cytidine Deaminase; DNA-Binding Proteins; Down Syndrome; Erythroid-Specific DNA-Binding Factors; GATA1 Transcription Factor; Humans; Leukemia, Megakaryoblastic, Acute; Polymerase Chain Reaction; Time Factors; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Up-Regulation | 2005 |
Long term cultured HL-60 cells are intrinsically resistant to Ara-C through high CDA activity.
Topics: Arabinofuranosylcytosine Triphosphate; Arabinofuranosyluracil; Cytarabine; Cytidine Deaminase; Drug Resistance, Neoplasm; HL-60 Cells; Humans; RNA, Messenger; RNA, Neoplasm | 2012 |
Simultaneous determination of 1-β-d-Arabinofuranosylcytosine and two metabolites, 1-β-d-Arabinofuranosyluracil and 1-β-d-Arabinofuranosylcytosine triphosphate in leukemic cell by HPLC-MS/MS and the application to cell pharmacokinetics.
Topics: Adult; Antimetabolites, Antineoplastic; Arabinofuranosylcytosine Triphosphate; Arabinofuranosyluracil; Cell Line, Tumor; Chromatography, High Pressure Liquid; Cytarabine; Humans; Limit of Detection; Middle Aged; Tandem Mass Spectrometry; Young Adult | 2014 |